Clinical, Biological, and Therapeutic Characteristics Between Depression with and Without Medical Illness

Chapter

Abstract

Comorbid medical illness with depression is quite a challenge to the successful treatment for both clinician and patient. First, chronic medical illness can make clinician confused to recognize and treat depression, by overlapped symptoms. Second, individuals having both depression and medical illness respond poorer with lower recovery rates, more impaired function, and higher relapse of depressive episodes than individuals with only depression. This poor therapeutic response often comes from poor adherence, comorbid somatic symptoms, and pain as stress which is hidden in other comorbidities. Decreased quality of life and increased costs accompany to this burdensome. Careful evaluation with MDD and comorbid medical illness followed by appropriate collaborative care can lead individuals to better prognosis in the future.

Keywords

Comorbidity Medical illness Endocrine Immune Pain 

References

  1. Aarsland D, Pahlhagen S, Ballard CG, Ehrt U, Svenningsson P. Depression in Parkinson disease—epidemiology, mechanisms and management. Nat Rev Neurol. 2011;8:35–47.CrossRefGoogle Scholar
  2. Andersen BL, et al. Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology guideline adaptation. J Clin Oncol. 2014;32:1605–19.CrossRefGoogle Scholar
  3. Arriens C, Hynan LS, Lerman RH, Karp DR, Mohan C. Placebo-controlled randomized clinical trial of fish oil's impact on fatigue, quality of life, and disease activity in systemic lupus erythematosus. Nutr J. 2015;14:82.CrossRefGoogle Scholar
  4. Bair MJ, Robinson RL, Katon W, Kroenke K. Depression and pain comorbidity: a literature review. Arch Intern Med. 2003;163:2433–45.CrossRefGoogle Scholar
  5. Bautovich A, Katz I, Smith M, Loo CK, Harvey SB. Depression and chronic kidney disease: a review for clinicians. Aust N Z J Psychiatry. 2014;48:530–41.CrossRefGoogle Scholar
  6. Benros ME, Waltoft BL, Nordentoft M, Ostergaard SD, Eaton WW, Krogh J, Mortensen PB. Autoimmune diseases and severe infections as risk factors for mood disorders: a nationwide study. JAMA Psychiat. 2013;70:812–20.CrossRefGoogle Scholar
  7. Breland JY, Mignogna J, Kiefer L, Marsh L. Models for treating depression in specialty medical settings: a narrative review. Gen Hosp Psychiatry. 2015;37:315–22.CrossRefGoogle Scholar
  8. Callahan CM, et al. Effectiveness of collaborative care for older adults with Alzheimer disease in primary care: a randomized controlled trial. JAMA. 2006;295:2148–57.CrossRefGoogle Scholar
  9. Carroll BJ, Iranmanesh A, Keenan DM, Cassidy F, Wilson WH, Veldhuis JD. Pathophysiology of hypercortisolism in depression: pituitary and adrenal responses to low glucocorticoid feedback. Acta Psychiatr Scand. 2012;125:478–91.CrossRefGoogle Scholar
  10. Carson AJ, MacHale S, Allen K, Lawrie SM, Dennis M, House A, Sharpe M. Depression after stroke and lesion location: a systematic review. Lancet. 2000;356:122–6.CrossRefGoogle Scholar
  11. Caughey GE, Roughead EE, Shakib S, McDermott RA, Vitry AI, Gilbert AL. Comorbidity of chronic disease and potential treatment conflicts in older people dispensed antidepressants. Age Ageing. 2010;39:488–94.CrossRefGoogle Scholar
  12. Cocksedge KA, Simon C, Shankar R. A difficult combination: chronic physical illness, depression, and pain. Br J Gen Pract. 2014;64:440–1.CrossRefGoogle Scholar
  13. Collins FS, Varmus H. A new initiative on precision medicine. N Engl J Med. 2015;372:793–5.CrossRefGoogle Scholar
  14. Cooper-Kazaz R, et al. Preliminary evidence that a functional polymorphism in type 1 deiodinase is associated with enhanced potentiation of the antidepressant effect of sertraline by triiodothyronine. J Affect Disord. 2009;116:113–6.CrossRefGoogle Scholar
  15. Currier MB, Nemeroff CB. Depression as a risk factor for cancer: from pathophysiological advances to treatment implications. Annu Rev Med. 2014;65:203–21.CrossRefGoogle Scholar
  16. De Kloet ER, Vreugdenhil E, Oitzl MS, Joels M. Brain corticosteroid receptor balance in health and disease. Endocr Rev. 1998;19:269–301.PubMedGoogle Scholar
  17. Demyttenaere K, et al. Presence and predictors of pain in depression: results from the FINDER study. J Affect Disord. 2010;125:53–60.CrossRefGoogle Scholar
  18. Diez-Quevedo C, et al. Depression, antidepressants, and long-term mortality in heart failure. Int J Cardiol. 2013;167:1217–25.CrossRefGoogle Scholar
  19. Dua T, et al. Evidence-based guidelines for mental, neurological, and substance use disorders in low- and middle-income countries: summary of WHO recommendations. PLoS Med. 2011;8:e1001122.CrossRefGoogle Scholar
  20. Egede LE. Major depression in individuals with chronic medical disorders: prevalence, correlates and association with health resource utilization, lost productivity and functional disability. Gen Hosp Psychiatry. 2007;29:409–16.CrossRefGoogle Scholar
  21. Enache D, Winblad B, Aarsland D. Depression in dementia: epidemiology, mechanisms, and treatment. Curr Opin Psychiatry. 2011;24:461–72.CrossRefGoogle Scholar
  22. Fan VS, et al. Sex, depression, and risk of hospitalization and mortality in chronic obstructive pulmonary disease. Arch Intern Med. 2007;167:2345–53.CrossRefGoogle Scholar
  23. Galic MA, Riazi K, Pittman QJ. Cytokines and brain excitability. Front Neuroendocrinol. 2012;33:116–25.CrossRefGoogle Scholar
  24. Gauthier S, et al. Recommendations of the 4th Canadian consensus conference on the diagnosis and treatment of dementia (CCCDTD4). Can Geriatr J. 2012;15:120–6.CrossRefGoogle Scholar
  25. Gonera EG, van't Hof M, Berger HJ, van Weel C, Horstink MW. Symptoms and duration of the prodromal phase in Parkinson’s disease. Mov Disord. 1997;12:871–6.CrossRefGoogle Scholar
  26. Grassi L, Caruso R, Sabato S, Massarenti S, Nanni MG, The UniFe Psychiatry Working Group C. Psychosocial screening and assessment in oncology and palliative care settings. Front Psychol. 2014;5:1485.PubMedGoogle Scholar
  27. Greenley RN, Hommel KA, Nebel J, Raboin T, Li SH, Simpson P, Mackner L. A meta-analytic review of the psychosocial adjustment of youth with inflammatory bowel disease. J Pediatr Psychol. 2010;35:857–69.CrossRefGoogle Scholar
  28. Hackett ML, Anderson CS. Predictors of depression after stroke: a systematic review of observational studies. Stroke. 2005;36:2296–301.CrossRefGoogle Scholar
  29. Hage MP, Azar ST. The link between thyroid function and depression. J Thyroid Res. 2012;2012:590648.CrossRefGoogle Scholar
  30. Hedayati SS, Finkelstein FO. Epidemiology, diagnosis, and management of depression in patients with CKD. Am J Kidney Dis. 2009;54:741–52.CrossRefGoogle Scholar
  31. Hort J, et al. EFNS guidelines for the diagnosis and management of Alzheimer’s disease. Eur J Neurol. 2010;17:1236–48.CrossRefGoogle Scholar
  32. Ihl R, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of Alzheimer’s disease and other dementias. World J Biol Psychiatry. 2011;12:2–32.CrossRefGoogle Scholar
  33. Janssen DJ, et al. Symptoms of anxiety and depression in COPD patients entering pulmonary rehabilitation. Chron Respir Dis. 2010;7:147–57.CrossRefGoogle Scholar
  34. Kantorova E, et al. Hypothalamic damage in multiple sclerosis correlates with disease activity, disability, depression, and fatigue. Neurol Res. 2017:1–8.Google Scholar
  35. Katon WJ. Epidemiology and treatment of depression in patients with chronic medical illness. Dialogues Clin Neurosci. 2011;13:7–23.PubMedGoogle Scholar
  36. Katon W, Lin EH, Kroenke K. The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. Gen Hosp Psychiatry. 2007;29:147–55.CrossRefGoogle Scholar
  37. Kelly WF. Psychiatric aspects of Cushing’s syndrome. QJM. 1996;89:543–51.CrossRefGoogle Scholar
  38. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606–13.CrossRefGoogle Scholar
  39. Langenecker SA, et al. Impact of chronic hypercortisolemia on affective processing. Neuropharmacology. 2012;62:217–25.CrossRefGoogle Scholar
  40. Lau D, Rutledge C, Aghi MK. Cushing’s disease: current medical therapies and molecular insights guiding future therapies. Neurosurg Focus. 2015;38:E11.CrossRefGoogle Scholar
  41. Lee YJ, Han SB, Nam SY, Oh KW, Hong JT. Inflammation and Alzheimer’s disease. Arch Pharm Res. 2010;33:1539–56.CrossRefGoogle Scholar
  42. Leonard BE. Inflammation and depression: a causal or coincidental link to the pathophysiology? Acta Neuropsychiatr. 2017:1–16.CrossRefGoogle Scholar
  43. Lyketsos CG, Hoover DR, Guccione M, Dew MA, Wesch JE, Bing EG, Treisman GJ. Changes in depressive symptoms as AIDS develops. The multicenter AIDS cohort study. Am J Psychiatry. 1996;153:1430–7.CrossRefGoogle Scholar
  44. Manea L, Gilbody S, McMillan D. Optimal cut-off score for diagnosing depression with the Patient Health Questionnaire (PHQ-9): a meta-analysis. CMAJ. 2012;184:E191–6.CrossRefGoogle Scholar
  45. Martin-Subero M, Anderson G, Kanchanatawan B, Berk M, Maes M. Comorbidity between depression and inflammatory bowel disease explained by immune-inflammatory, oxidative, and nitrosative stress; tryptophan catabolite; and gut-brain pathways. CNS Spectr. 2016;21:184–98.CrossRefGoogle Scholar
  46. Mavrides N, Nemeroff C. Treatment of depression in cardiovascular disease. Depress Anxiety. 2013;30:328–41.CrossRefGoogle Scholar
  47. Means-Christensen AJ, Roy-Byrne PP, Sherbourne CD, Craske MG, Stein MB. Relationships among pain, anxiety, and depression in primary care. Depress Anxiety. 2008;25:593–600.CrossRefGoogle Scholar
  48. Miller CJ, Grogan-Kaylor A, Perron BE, Kilbourne AM, Woltmann E, Bauer MS. Collaborative chronic care models for mental health conditions: cumulative meta-analysis and metaregression to guide future research and implementation. Med Care. 2013;51:922–30.CrossRefGoogle Scholar
  49. Mitchell AJ, Subramaniam H. Prognosis of depression in old age compared to middle age: a systematic review of comparative studies. Am J Psychiatry. 2005;162:1588–601.CrossRefGoogle Scholar
  50. Mitchell AJ, Chan M, Bhatti H, Halton M, Grassi L, Johansen C, Meader N. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol. 2011;12:160–74.CrossRefGoogle Scholar
  51. Montazeri A, Milroy R, Hole D, McEwen J, Gillis CR. Anxiety and depression in patients with lung cancer before and after diagnosis: findings from a population in Glasgow, Scotland. J Epidemiol Community Health. 1998;52:203–4.CrossRefGoogle Scholar
  52. Morel-Kopp MC, McLean L, Chen Q, Tofler GH, Tennant C, Maddison V, Ward CM. The association of depression with platelet activation: evidence for a treatment effect. J Thromb Haemost. 2009;7:573–81.CrossRefGoogle Scholar
  53. Moulton CD, Pickup JC, Ismail K. The link between depression and diabetes: the search for shared mechanisms. Lancet Diabetes Endocrinol. 2015;3:461–71.CrossRefGoogle Scholar
  54. Myint AM, Kim YK. Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression. Med Hypotheses. 2003;61:519–25.CrossRefGoogle Scholar
  55. Mystakidou K, Parpa E, Tsilika E, Panagiotou I, Zygogianni A, Giannikaki E, Gouliamos A. Geriatric depression in advanced cancer patients: the effect of cognitive and physical functioning. Geriatr Gerontol Int. 2013;13:281–8.CrossRefGoogle Scholar
  56. Narasimhan M, Raynor JD, Jones AB. Depression in the medically ill: diagnostic and therapeutic implications. Curr Psychiatry Rep. 2008;10:272–9.CrossRefGoogle Scholar
  57. Nutt DJ, et al. International consensus statement on major depressive disorder. J Clin Psychiatry. 2010;71(Suppl E1):e08.PubMedGoogle Scholar
  58. Orgeta V, Qazi A, Spector AE, Orrell M. Psychological treatments for depression and anxiety in dementia and mild cognitive impairment. Cochrane Database Syst Rev. 2014:CD009125.Google Scholar
  59. Orsi G, Ghelardoni S, Saba A, Zucchi R, Vozzi G. Characterization of 3-iodothyronamine in vitro dynamics by mathematical modeling. Cell Biochem Biophys. 2014;68:37–47.CrossRefGoogle Scholar
  60. Osswald A, et al. Favorable long-term outcomes of bilateral adrenalectomy in Cushing’s disease. Eur J Endocrinol. 2014;171:209–15.CrossRefGoogle Scholar
  61. Ottolini F, Modena MG, Rigatelli M. Prodromal symptoms in myocardial infarction. Psychother Psychosom. 2005;74:323–7.CrossRefGoogle Scholar
  62. Pace TW, Miller AH. Cytokines and glucocorticoid receptor signaling. Relevance to major depression. Ann N Y Acad Sci. 2009;1179:86–105.CrossRefGoogle Scholar
  63. Palmer S, et al. Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies. Kidney Int. 2013;84:179–91.CrossRefGoogle Scholar
  64. Petrak F, Baumeister H, Skinner TC, Brown A, Holt RI. Depression and diabetes: treatment and health-care delivery. Lancet Diabetes Endocrinol. 2015;3:472–85.CrossRefGoogle Scholar
  65. Qaseem A, Barry MJ, Kansagara D, Clinical Guidelines Committee of the American College of P. Nonpharmacologic versus pharmacologic treatment of adult patients with major depressive disorder: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2016;164:350–9.CrossRefGoogle Scholar
  66. Quan N, Avitsur R, Stark JL, He L, Lai W, Dhabhar F, Sheridan JF. Molecular mechanisms of glucocorticoid resistance in splenocytes of socially stressed male mice. J Neuroimmunol. 2003;137:51–8.CrossRefGoogle Scholar
  67. Reed-Knight B, et al. Depressive symptoms in youth with inflammatory bowel disease compared with a community sample. Inflamm Bowel Dis. 2014;20:614–21.CrossRefGoogle Scholar
  68. Robinson RG. Poststroke depression: prevalence, diagnosis, treatment, and disease progression. Biol Psychiatry. 2003;54:376–87.CrossRefGoogle Scholar
  69. Segerstrom SC, Miller GE. Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol Bull. 2004;130:601–30.CrossRefGoogle Scholar
  70. Smith SM, Wallace E, O'Dowd T, Fortin M. Interventions for improving outcomes in patients with multimorbidity in primary care and community settings. Cochrane Database Syst Rev. 2016;3:CD006560.PubMedGoogle Scholar
  71. Sonino N, Fava GA. Psychiatric disorders associated with Cushing’s syndrome. Epidemiology, pathophysiology and treatment. CNS Drugs. 2001;15:361–73.CrossRefGoogle Scholar
  72. Sonino N, Fava GA, Belluardo P, Girelli ME, Boscaro M. Course of depression in Cushing’s syndrome: response to treatment and comparison with Graves’ disease. Horm Res. 1993;39:202–6.CrossRefGoogle Scholar
  73. Sonino N, Fava GA, Raffi AR, Boscaro M, Fallo F. Clinical correlates of major depression in Cushing’s disease. Psychopathology. 1998;31:302–6.CrossRefGoogle Scholar
  74. Sorbi S, et al. EFNS-ENS guidelines on the diagnosis and management of disorders associated with dementia. Eur J Neurol. 2012;19:1159–79.CrossRefGoogle Scholar
  75. Sternbach HA, Gold MS, Pottash AC, Extein I. Thyroid failure and protirelin (thyrotropin-releasing hormone) test abnormalities in depressed outpatients. JAMA. 1983;249:1618–20.CrossRefGoogle Scholar
  76. Taylor D, et al. Pharmacological interventions for people with depression and chronic physical health problems: systematic review and meta-analyses of safety and efficacy. Br J Psychiatry. 2011;198:179–88.CrossRefGoogle Scholar
  77. Tirabassi G, Boscaro M, Arnaldi G. Harmful effects of functional hypercortisolism: a working hypothesis. Endocrine. 2014;46:370–86.CrossRefGoogle Scholar
  78. Tsukahara K, Sugitani I, Fujimoto Y, Kawabata K. Surgery did not improve the subjective neuropsychological symptoms of patients with incidentally detected mild primary hyperparathyroidism. Eur Arch Otorhinolaryngol. 2008;265:565–9.CrossRefGoogle Scholar
  79. Watson L, Baird J, Hosel V, Peveler R. The effect of concurrent pain on the management of patients with depression: an analysis of NHS healthcare resource utilisation using the GPRD database. Int J Clin Pract. 2009;63:698–706.CrossRefGoogle Scholar
  80. Whooley MA, et al. Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA. 2008;300:2379–88.CrossRefGoogle Scholar
  81. Woltmann E, Grogan-Kaylor A, Perron B, Georges H, Kilbourne AM, Bauer MS. Comparative effectiveness of collaborative chronic care models for mental health conditions across primary, specialty, and behavioral health care settings: systematic review and meta-analysis. Am J Psychiatry. 2012;169:790–804.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2018

Authors and Affiliations

  1. 1.Department of NeuropsychiatrySeoul National University Bundang HospitalSeongnamSouth Korea
  2. 2.Department of Psychiatry, Depression Center, Samsung Medical CenterSungkyunkwan University School of MedicineSeoulSouth Korea

Personalised recommendations